{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:56Z","timestamp":1791357536977,"version":"4.3.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Janssen-Cilag S.A.","award":["CP040592"],"award-info":[{"award-number":["CP040592"]}]},{"name":"Innovation, Universities and Enterprise Authority","award":["DURSI 2009SGR1295"],"award-info":[{"award-number":["DURSI 2009SGR1295"]}]},{"name":"Innovation, Universities and Enterprise Authority","award":["2009SGR1501"],"award-info":[{"award-number":["2009SGR1501"]}]},{"name":"Spanish Ministry of Health, Instituto de Salud Carlos III","award":["CD09\/00296"],"award-info":[{"award-number":["CD09\/00296"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.pnpbp.2011.08.010","type":"journal-article","created":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T00:48:43Z","timestamp":1314060523000},"page":"71-77","source":"Crossref","is-referenced-by-count":60,"title":["Neurotoxic\/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells"],"prefix":"10.1016","volume":"36","author":[{"given":"Patricia","family":"Gass\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Lafuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Parellada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2011.08.010_bb0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0893-133X(88)90012-7","article-title":"The current status of the dopamine hypothesis of schizophrenia","volume":"1","author":"Carlsson","year":"1988","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0010","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM199403103301006","article-title":"Schizophrenia","volume":"330","author":"Carpenter","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0015","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/385434a0","article-title":"Bcl-2 promotes regeneration of severed axons in mammalian CNS","volume":"385","author":"Chen","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0020","first-page":"251","article-title":"Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism","volume":"60","author":"Chiueh","year":"1993","journal-title":"Adv Neurol"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0025","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1440-1681.2008.04918.x","article-title":"CYP2D6 *3, *4, *5 and *6 polymorphisms and antipsychotic-induced extrapyramidal side effects in patients receiving antipsychotic therapy","volume":"35","author":"Crescenti","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0030","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1517\/14656566.9.9.1451","article-title":"Antipsychotic-induced extrapyramidal symptoms and their management","volume":"9","author":"Dayalu","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0035","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","article-title":"Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects","volume":"49","author":"Farde","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0040","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s007020070089","article-title":"Haloperidol-induced neurotoxicity\u2013possible implications for tardive dyskinesia","volume":"107","author":"Galili","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0045","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/tpj.2009.26","article-title":"A common variant in DRD3 gene is associated with antipsychotic induced extrapyramidal symptoms","volume":"9","author":"Gass\u00f3","year":"2009","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.psychres.2009.07.006","article-title":"Lack of association between antipsychotic-induced extrapyramidal symptoms and polymorphisms in dopamine metabolism and transport genes","volume":"175","author":"Gass\u00f3","year":"2010","journal-title":"Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0055","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.euroneuro.2010.06.006","article-title":"Searching for functional SNPs or rare variants in exonic regions of DRD3 in risperidone-treated patients","volume":"21","author":"Gass\u00f3","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0060","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1023\/A:1015152021192","article-title":"Evaluation of the neurotoxic activity of typical and atypical neuroleptics: relevance to iatrogenic extrapyramidal symptoms","volume":"21","author":"Gil-ad","year":"2001","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/tpj.2008.6","article-title":"Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3\u2032-untranslated region","volume":"9","author":"Greenbaum","year":"2009","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0070","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1124\/jpet.106.110866","article-title":"Protective effect of sulforaphane against dopaminergic cell death","volume":"321","author":"Han","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-5793(04)00082-1","article-title":"The effects of clozapine on the GSK-3-mediated signaling pathway","volume":"560","author":"Kang","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0080","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","article-title":"Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia","volume":"157","author":"Kapur","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.pnpbp.2007.11.002","article-title":"Protective effects of olanzapine and haloperidol on serum withdrawal-induced apoptosis in SH-SY5Y cells","volume":"32","author":"Kim","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.schres.2006.09.031","article-title":"Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics","volume":"90","author":"Lafuente","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.psychres.2007.08.002","article-title":"Polymorphism of Dopamine D2 receptor (TaqIA, TaqIB, and -141C Ins\/Del) and Dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders","volume":"161","author":"Lafuente","year":"2008","journal-title":"Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2184.1991.tb01150.x","article-title":"Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli","volume":"24","author":"Lennon","year":"1991","journal-title":"Cell Prolif"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0105","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/070674379804300608","article-title":"Typical and atypical antipsychotics in adolescent schizophrenia: efficacy, tolerability, and differential sensitivity to extrapyramidal symptoms","volume":"43","author":"Lewis","year":"1998","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0110","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1124\/pr.107.00107","article-title":"Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection","volume":"60","author":"Lieberman","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.psychres.2006.08.007","article-title":"Association analysis of polymorphisms in the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GRIN2B) gene and tardive dyskinesia in schizophrenia","volume":"153","author":"Liou","year":"2007","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0120","article-title":"Intuitive pharmacogenetics: spontaneous risperidone dosage is related to CYP2D6, CYP3A5 and ABCB1 genotypes","author":"Mas","year":"2010","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0125","series-title":"Drug Class Review: Atypical Antipsychotic Drugs: Final Update 3 Report","author":"McDonagh","year":"2010"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0130","first-page":"28","article-title":"Tolerability profiles of atypical antipsychotics in the treatment of bipolar disorders","volume":"66","author":"McIntyre","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2011.02.007","article-title":"The role of serotonin receptors in the action of atypical antipsychotic drugs","volume":"11","author":"Meltzer","year":"2011","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0140","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pharmthera.2009.06.001","article-title":"Antipsychotic drug actions on gene modulation and signaling mechanisms","volume":"124","author":"Molteni","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0145","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1046\/j.1471-4159.2000.0752327.x","article-title":"Haloperidol-induced neuronal apoptosis: role of p38 and c-Jun-NH(2)-terminal protein kinase","volume":"75","author":"Noh","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0167-4889(95)00075-4","article-title":"Dopamine-induced programmed cell death in mouse thymocytes","volume":"1268","author":"Offen","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0155","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1046\/j.1460-9568.2003.02590.x","article-title":"The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+\u2212induced apoptosis","volume":"17","author":"Qing","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0160","first-page":"15","article-title":"D2 and 5HT2 receptor effects of antipsychotic; bridging basic and clinical findings using PET","volume":"60","author":"Remington","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0165","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00702-004-0109-z","article-title":"Neurotoxic potential of haloperidol in comparison with risperidone: implication of Akt-mediated signal changes by haloperidol","volume":"111","author":"Ukai","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0170","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jnr.10668","article-title":"Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide","volume":"73","author":"Wei","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0175","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/jnr.10832","article-title":"Atypical antipsychotics attenuate neurotoxicity of beta-amyloid(25\u201335) by modulating Bax and Bcl-X(l\/s) expression and localization","volume":"74","author":"Wei","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0180","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.4088\/JCP.v68n0906","article-title":"Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population","volume":"68","author":"Xu","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0185","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/FPC.0b013e3282f85e26","article-title":"BDNF gene is a genetic risk factor for schizophrenia and is related to the chlorpromazine-induced extrapyramidal syndrome in the Chinese population","volume":"18","author":"Xu","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0190","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1440-1819.2004.01229.x","article-title":"Phosphorylation of ERK and CREB in cultured hippocampal neurons after haloperidol and risperidone administration","volume":"58","author":"Yang","year":"2004","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0195","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.neuint.2006.09.015","article-title":"Haloperidol induces neurotoxicity by the NMDA receptor downstream signalling pathway, alternative from glutamate excitotoxicity","volume":"50","author":"Zhuravliova","year":"2007","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pnpbp.2011.08.010_bb0200","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0304-3940(94)90258-5","article-title":"Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons\u2014a possible novel pathogenetic mechanism in Parkinson's disease","volume":"170","author":"Ziv","year":"1994","journal-title":"Neurosci Lett"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611002570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611002570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T15:26:56Z","timestamp":1543591616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584611002570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0278584611002570"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.08.010","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}